Lung Cancer Screening & Tobacco Cessation Trial Enrollment
“`html
Improving Diversity in Tobacco Cessation clinical Trials: Key Findings from Screen ASSIST
Table of Contents
A subanalysis of the Screen ASSIST trial reveals sociodemographic and healthcare factors linked to higher enrollment rates, offering opportunities to address disparities in lung cancer and smoking-related disease outcomes.
What Happened: Screen ASSIST Trial Subanalysis
A recent subanalysis of the Screen ASSIST (NCT03611881) clinical trial, presented at the 2025 World Conference on Lung Cancer, investigated factors associated with enrollment in a tobacco cessation program integrated with lung cancer screening. The trial aimed to help patients undergoing lung cancer screening who were current smokers to quit through counseling, nicotine replacement therapy, and connection to local resources based on social determinants of health.
Researchers analyzed data from over 4000 eligible patients, finding that 15.7% enrolled in the trial – a rate consistent with typical tobacco cessation trials, but lower than some other clinical trial types. Crucially,the analysis identified specific sociodemographic and healthcare-related factors associated with a *higher* likelihood of enrollment.
Why It Matters: Addressing Disparities in Clinical Trial Participation
Clinical trial participation is frequently enough skewed, leading to results that may not be generalizable to all populations. Historically,certain demographic groups are underrepresented,exacerbating health disparities. This subanalysis of Screen ASSIST is meaningful as it identifies factors that can be leveraged to *increase* participation among those historically less likely to enroll.
Improving diversity in clinical trials is essential for several reasons:
- More Accurate Results: Diverse populations respond differently to treatments. Including a wider range of participants ensures that findings are applicable to a broader patient base.
- Equitable Healthcare: Underrepresentation can lead to treatments that are less effective or even harmful for certain groups.
- Ethical Considerations: All populations should have equal access to the potential benefits of medical research.
Key Findings: Factors Associated with Higher Enrollment
While the full details of the findings are still being presented, initial reports indicate that several factors were associated with increased enrollment in the Screen ASSIST trial. These included:
| Factor | Association with Enrollment |
|---|---|
| Specific Sociodemographic Characteristics (details pending full publication) | Higher likelihood of enrollment |
| access to Healthcare Resources | Higher likelihood of enrollment |
| Engagement with Lung Cancer Screening Program | Higher likelihood of enrollment |
Further analysis is needed to determine the relative importance of each factor and to identify specific interventions that can be used to address barriers to participation.